KCTD1 and adrenal cortex carcinoma: Thus, the epidermal defect in ACC in patients with KCTD1 or KCTD15 mutations is likely a secondary consequence of abnormalities in cranial NCC-derived mesenchymal cell populations that lack KCTD1/KCTD15 function.